<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000423254">
  <TermName>SJG-136</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called DNA cross-linking agents.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>SJG-136</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Es un tipo de formador de enlaces transversales en el ADN.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2005-05-23</DateFirstPublished>
</GlossaryTerm>
